These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 37665139

  • 1. Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.
    Chiang J, Rajendran PS, Hao F, Sayre J, Raman SS, Lu DSK, McWilliams JP.
    Diagn Interv Radiol; 2023 Nov 07; 29(6):805-812. PubMed ID: 37665139
    [Abstract] [Full Text] [Related]

  • 2. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, Lubner MG, Dalvie PS, Louis Hinshaw J, Brace CL, Ozkan OS, Lee FT, Laeseke P.
    Abdom Radiol (NY); 2018 Sep 07; 43(9):2497-2504. PubMed ID: 29450606
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T, Qi H, Shen L, Wu Y, Song Z, Cao F, Liu Y, Xie L, Chen S, Tang T, Li H, Zhang Y, Feng L, Zhang H, Chen J, Fan W.
    Int J Hyperthermia; 2022 Sep 07; 39(1):935-945. PubMed ID: 35853727
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
    Miyamoto N, Kanaya M, Fujii T, Kato H, Kudo K, Kinota N.
    Jpn J Radiol; 2021 Apr 07; 39(4):376-386. PubMed ID: 33150469
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression.
    Cao S, Zou Y, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J.
    Int J Hyperthermia; 2022 Apr 07; 39(1):1-7. PubMed ID: 34937501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, Wu SS, Yu J, Liang P, Huang J.
    Eur Radiol; 2021 Jul 07; 31(7):4764-4773. PubMed ID: 33399908
    [Abstract] [Full Text] [Related]

  • 12. Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.
    Chen G, Chen H, Huang X, Cheng S, Zheng S, Wu Y, Zheng T, Chen X, Guo X, Zhang Z, Xie X, Zhang B.
    Medicina (Kaunas); 2022 Jul 29; 58(8):. PubMed ID: 36013483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score.
    Zhu ZY, Yuan M, Yang PP, Xie B, Wei JZ, Qin ZQ, Qian Z, Wang ZY, Fan LF, Qian JY, Tan YL.
    World J Surg Oncol; 2022 Jun 10; 20(1):192. PubMed ID: 35689233
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis.
    Zhao J, Wu J, He M, Cao M, Lei J, Luo H, Yi F, Ding J, Wei Y, Zhang W.
    Int J Hyperthermia; 2020 Jun 10; 37(1):624-633. PubMed ID: 32525724
    [Abstract] [Full Text] [Related]

  • 18. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P, Zhang Z, Kuai J.
    J BUON; 2019 Jun 10; 24(1):163-170. PubMed ID: 30941966
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.